CDEK by Data4ThePeople

Sign in Sign up

← All organizations

X-act Cologne Clinical Research GmbH

X-act Cologne Clinical Research GmbH

For profitWebsite ↗

Also known as: X-act Cologne Clinical Research GmbH | X-act Cologne Research GmbH

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Mar 1, 2022

Timeline

1990s

Jan 1, 1994
X-act Cologne Clinical Research GmbH— Founded

2010s

Apr 1, 2019
WiSP GmbH— Acquired

Drugs by trial phase (32 distinct, 17 trials)

Phase 3 (0 own, 11 via acquisition)

Phase 2 (3 own, 15 via acquisition)

Phase 1 (0 own, 1 via acquisition)

mitomycin c-induced peripheral blood mononuclear cells

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

WiSP GmbH

Recent trials (3)

NCT04268277CollaboratorN/AMar 1, 2022
NCT03592342CollaboratorPhase 2Jun 28, 2018
NCT01621256CollaboratorPhase 1/Phase 2May 1, 2013

Details

Founded: Cologne, DE Jan 1, 1994
Last known activity: Mar 1, 2022